Skip to Content
Merck
All Photos(1)

Key Documents

A0773

Sigma-Aldrich

Angiotensin Converting Enzyme Inhibitor

≥95% (TLC)

Sign Into View Organizational & Contract Pricing

Select a Size

1 MG
R$1,450.00
5 MG
R$3,137.00

R$1,450.00


Estimated to ship onApril 12, 2025


Request a Bulk Order

Select a Size

Change View
1 MG
R$1,450.00
5 MG
R$3,137.00

About This Item

Empirical Formula (Hill Notation):
C53H76N14O12
CAS Number:
Molecular Weight:
1101.26
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77

R$1,450.00


Estimated to ship onApril 12, 2025


Request a Bulk Order

biological source

synthetic (organic)

Quality Level

Assay

≥95% (TLC)

form

powder

mol wt

~_1.1 kDa

solubility

water: soluble 1 mg/mL, clear, colorless

storage temp.

−20°C

SMILES string

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(O)=O

InChI

1S/C53H76N14O12/c1-3-29(2)43(51(77)66-25-9-16-39(66)50(76)67-26-10-17-40(67)52(78)79)63-45(71)34(18-20-41(54)68)60-46(72)37-14-7-23-64(37)48(74)35(13-6-22-57-53(55)56)61-47(73)38-15-8-24-65(38)49(75)36(62-44(70)33-19-21-42(69)59-33)27-30-28-58-32-12-5-4-11-31(30)32/h4-5,11-12,28-29,33-40,43,58H,3,6-10,13-27H2,1-2H3,(H2,54,68)(H,59,69)(H,60,72)(H,61,73)(H,62,70)(H,63,71)(H,78,79)(H4,55,56,57)/t29-,33-,34-,35-,36-,37-,38-,39-,40-,43-/m0/s1

InChI key

UUUHXMGGBIUAPW-CSCXCSGISA-N

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Of mice and men: therapeutic mTOR inhibition in polycystic kidney disease.
York Pei
Journal of the American Society of Nephrology : JASN, 21(3), 390-391 (2010-02-06)
Claudia Bello et al.
Bioorganic & medicinal chemistry, 18(9), 3320-3334 (2010-03-30)
Novel alpha-mannosidase inhibitors of the type (2R,3R,4S)-2-({[(1R)-2-hydroxy-1-arylethyl]amino}methyl)pyrrolidine-3,4-diol have been prepared and assayed for their anticancer activities. Compound 30 with the aryl group=4-trifluoromethylbiphenyl inhibits the proliferation of primary cells and cell lines of different origins, irrespective of Bcl-2 expression levels, inducing
Oscar Gallardo et al.
The Journal of biological chemistry, 285(4), 2721-2733 (2009-11-27)
Paenibacillus barcinonensis is a soil bacterium bearing a complex set of enzymes for xylan degradation, including several secreted enzymes and Xyn10B, one of the few intracellular xylanases reported to date. The crystal structure of Xyn10B has been determined by x-ray
Mark Fahey et al.
The Journal of rheumatology, 36(1), 163-169 (2009-01-10)
Calcium pyrophosphate dihydrate (CPPD) crystals are commonly found in osteoarthritic joints and correlate with a poor prognosis. Intraarticular corticosteroids, such as dexamethasone (Dxm), are commonly used therapies for osteoarthritis with or without CPPD deposition. Dxm has variable effects in mineralization
Karly C Sourris et al.
American journal of nephrology, 30(4), 323-335 (2009-06-27)
A commonality among the chemically disparate compounds that inhibit the formation and accumulation of advanced glycation end products (AGEs) or their signalling pathways is their end organ protection in experimental models of diabetes complications. Although this group of therapeutics are

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service